VIGL - Vigil Neuroscience to Present in Upcoming June Investor Conferences | Benzinga
WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (NASDAQ:VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced management's participation at two upcoming investor conferences.
- Ivana Magov?evi?-Liebisch, Ph.D., J.D., President & Chief Executive Officer and David Gray, Ph.D., Chief Science Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6th at 9:30 a.m. E.T.
- Ivana Magov?evi?-Liebisch, Ph.D., J.D., President & Chief Executive Officer, will present at the Goldman Sachs Global Healthcare Conference on Tuesday, June 11th at 10:40 a.m. ...